Celecoxib-mediated activation of endoplasmic reticulum stress induces de novo ceramide biosynthesis and apoptosis in hepatoma HepG2 cells
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Ceramides are the major sphingolipid metabolites involved in cell survival and apoptosis. When HepG2 hepatoma cells were treated with celecoxib, the expression of the genes in de novo sphingolipid biosynthesis and sphingomyelinase pathway was upregulated and cellular ceramide was elevated. In addition, celecoxib induced endoplasmic reticulum (ER) stress in a time-dependent manner. SPTLC2, a subunit of serine palmitoyltransferase, was overexpressed by adenovirus. Adenoviral overexpression of SPTLC2 (AdSPTLC2) decreased cell viability of HEK293 and HepG2 cells. In addition, AdSPTLC2 induced apoptosis via the caspase-dependent apoptotic pathway and elevated cellular ceramide, sphingoid bases, and dihydroceramide. However, overexpression of SPTLC2 did not induce ER stress. Collectively, celecoxib activates de novo sphingolipid biosynthesis and the combined effects of elevated ceramide and transcriptional activation of ER stress induce apoptosis. However, activation of de novo sphingolipid biosynthesis does not activate ER stress in hepatoma cells and is distinct from the celecoxib-mediated activation of ER stress.
Abstract
Ceramides are the major sphingolipid metabolites involved in cell survival and apoptosis. When HepG2 hepatoma cells were treated with celecoxib, the expression of the genes in de novo sphingolipid biosynthesis and sphingomyelinase pathway was upregulated and cellular ceramide was elevated. In addition, celecoxib induced endoplasmic reticulum (ER) stress in a time-dependent manner. SPTLC2, a subunit of serine palmitoyltransferase, was overexpressed by adenovirus. Adenoviral overexpression of SPTLC2 (AdSPTLC2) decreased cell viability of HEK293 and HepG2 cells. In addition, AdSPTLC2 induced apoptosis via the caspase-dependent apoptotic pathway and elevated cellular ceramide, sphingoid bases, and dihydroceramide. However, overexpression of SPTLC2 did not induce ER stress. Collectively, celecoxib activates de novo sphingolipid biosynthesis and the combined effects of elevated ceramide and transcriptional activation of ER stress induce apoptosis. However, activation of de novo sphingolipid biosynthesis does not activate ER stress in hepatoma cells and is distinct from the celecoxib-mediated activation of ER stress.
참고문헌 (34)
- Kitatani K, "The sphingolipid salvage pathway in ceramide metabolism and signaling", Cell Signal, 20, pp.1010~1018 (2008)
- Menaldino DS, "Sphingoid bases and de novo ceramide synthesis: enzymes involved, pharmacology and mechanisms of action", Pharmacol Res, 47, pp.373~381 (2003)
- Brenner B, "Fas", CD95, Cell Death Differ, pp.1998, 5[DOI]
- Goldkorn T, "H2O2 acts on cellular membranes to generate ceramide signaling and initiate apoptosis in tracheobronchial epithelial cells", J Cell Sci, 111(Pt 21), pp.3209~3220 (1998)
- Jenkins GM, "Acute activation of de novo sphingolipid biosynthesis upon heat shock causes an accumulation of ceramide and subsequent dephosphorylation of SR proteins", J Biol Chem, 277, pp.42572~42578 (2002)
- Baran Y, "Alterations of ceramide", sphingosine 1-phosphate rheostat involved in the regulation of resistance to imatinib-induced apoptosis in K562 human chronic myeloid leukemia cells, 2007, pp.282, 10922~10934
- Wang H, "N-(4-hydroxyphenyl)retinamide elevates ceramide in neuroblastoma cell lines by coordinate activation of serine palmitoyltransferase and ceramide synthase", Cancer Res, 61, pp.5102~5105 (2001)
- Perry DK, "Serine palmitoyltransferase regulates de novo ceramide generation during etoposide-induced apoptosis", J Biol Chem, 275, pp.9078~9084 (2000)
- Grosch S, "COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib", FASEB J, 15, pp.2742~2744 (2001)
- 김희승, "Cyclooxygenase-1 and -2: Molecular Targets for Cervical Neoplasia", 대한암예방학회지, 18(2), pp.123~134 (2013), 대한암예방학회
- Zhang H, "Combining sorafenib with celecoxib synergistically inhibits tumor growth of non-small cell lung cancer cells in vitro and in vivo", Oncol Rep, 31, pp.1954~1960 (2014)
- Schiffmann S, "The selective COX-2 inhibitor celecoxib modulates sphingolipid synthesis", J Lipid Res, 50, pp.32~40 (2009)
- Truman JP, "Evolving concepts in cancer therapy through targeting sphingolipid metabolism", Biochim Biophys Acta, 1841, pp.1174~1188 (2014)
- Schroder M, "ER stress and the unfolded protein response", Mutat Res, 569, pp.29~63 (2005)
- Puthalakath H, "ER stress triggers apoptosis by activating BH3-only protein Bim", Cell, 129, pp.1337~1349 (2007)
- Kucuksayan E, "Neutral sphingomyelinase inhibition decreases ER stress-mediated apoptosis and inducible nitric oxide synthase in retinal pigment epithelial cells", Free Radic Biol Med, 72, pp.113~123 (2014)
- Senkal CE, "Antiapoptotic roles of ceramidesynthase- 6-generated C16-ceramide via selective regulation of the ATF6", CHOP arm of ER-stress-response pathways, 2010, pp.24, 296~308
- Senkal CE, "Alteration of ceramide synthase 6", C16-ceramide induces activating transcription factor 6-mediated endoplasmic reticulum (ER) stress and apoptosis via perturbation of cellular Ca2+ and ER, J Biol Chem, pp.2011, 286[DOI]
- Hannun YA, "Ceramide in the eukaryotic stress response", Trends Cell Biol, 10, pp.73~80 (2000)
- Kolesnick R, "The therapeutic potential of modulating the ceramide", sphingomyelin pathway, 2002, pp.110, 3~8
- Hirayama A, "Assessing the cardiovascular risk between celecoxib and nonselective nonsteroidal antiinflammatory drugs in patients with rheumatoid arthritis and osteoarthritis", Cir J, 78, pp.194~205 (2014)
- Pereira PA, "Celecoxib improves host defense through prostaglandin inhibition during Histoplasma capsulatum infection", Mediators Inflamm, 2013, pp.950981~ (2013)
- Tsuji S, "Celecoxib, a selective cyclooxygenase-2 inhibitor, reduces level of a bone resorption marker in postmenopausal women with rheumatoid arthritis", Int J Rheum Dis, 17, pp.44~49 (2014)
- Schiffmann S, "The selective COX-2 inhibitor celecoxib modulates sphingolipid synthesis", J Lipid Res, 50, pp.32~40 (2009)
- Hla T, "C16:0-ceramide signals insulin resistance", Cell Metab, 20, pp.703~705 (2014)
- Park JW, "Ceramide synthases as potential targets for therapeutic intervention in human diseases", Biochim Biophys Acta, 1841, pp.671~681 (2014)
- Liu X, "Acid ceramidase inhibition: a novel target for cancer therapy", Front Biosci, 13, pp.2293~2298 (2008)
- Tamehiro N, "SPTLC1 binds ABCA1 to negatively regulate trafficking and cholesterol efflux activity of the transporter", Biochemistry, 47, pp.6138~6147 (2008)
- Tamehiro N, "Cell polarity factor Par3 binds SPTLC1 and modulates monocyte serine palmitoyltransferase activity and chemotaxis", J Biol Chem, 284, pp.24881~24890 (2009)
- Luo J, "A protocol for rapid generation of recombinant adenoviruses using the AdEasy system", Nat Protoc, 2, pp.1236~1247 (2007)
- Liang Chen, "IGF1 potentiates BMP9-induced osteogenic differentiation in mesenchymal stem cells through the enhancement of BMP", Smad signaling, 2016, pp.49(2), 122~127[DOI]
- 오아름, "Ursodeoxycholic acid decreases age-related adiposity and inflammation in mice", BMB Reports, 49(2), pp.105~110 (2016), 생화학분자생물학회
- Lee SY, "Activation of sphingosine kinase 2 by endoplasmic reticulum stress ameliorates hepatic steatosis and insulin resistance in mice", Hepatology, 62, pp.135~146 (2015)
- Yoo HH, "Liquid chromatography- tandem mass spectrometric determination of ceramides and related lipid species in cellular extracts", J Chromatogr B Analyt Technol Biomed Life Sci, 843, pp.327~333 (2006)
